[1] 王瑛,袁鹤立,赵利,等.伴营养不良风险的原发性肝癌患者临床特征及预后因素分析[J].中西医结合肝病杂志,2022,32(6):494-498.
[2] BULLOCK A F,GREENLEY S L,MCKENZIE G A G,et al.Relationship between markers of malnutrition and clinical outcomes in older adults with cancer:systematic review,narrative synthesis and meta-analysis[J].Eur J Clin Nutr,2020,74(11):1519-1535.
[3] 胡相友,易明超,卢攀.肝癌切除术和TACE治疗后肿瘤复发的预测模型构建与评估[J].现代医学,2022,50(1):41-46.
[4] OMIYA S,URADE T,KOMATSU S,et al.Impact of GLIM criteria-based malnutrition diagnosis on outcomes following liver resection for hepatocellular carcinoma[J].HPB (Oxford),2023,25(12):1555-1565.
[5] MIWA T,HANAI T,NISHIMURA K,et al.Usefulness of the Global Leadership Initiative on Malnutrition criteria to predict sarcopenia and mortality in patients with chronic liver disease[J].Hepatol Res,2022,52(11):928-936.
[6] 中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗规范(2019年版)[J].临床肝胆病杂志,2020,36(2):277-292.
[7] 姚晶,李鸿,夏东.预后营养指数对原发性肝癌肝切除术后感染性并发症的预测价值[J].现代肿瘤医学,2022,30(16):2961-2964.
[8] 林赛短,王云,陈家诚,等.肝癌患者疾病接受度现状及影响因素分析[J].现代医学,2023,51(4):468-473.
[9] SALAS S,COTTET V,DOSSUS L,et al.Nutritional factors during and after cancer:impacts on survival and quality of life[J].Nutrients,2022,14(14):2958.
[10] 蒋婷婷,孙芳芳,曾湛,等.代谢相关脂肪性肝病相关肝癌研究进展[J].中国肝脏病杂志(电子版),2022,14(3):14-17.
[11] 徐婷,张存泰.免疫衰老和老年营养[J].中国临床保健杂志,2023,26(4):446-451.
[12] 尹倩,王桦,章桂芬,等.湖北钟祥市长寿老人贫血与营养状况相关性分析[J].中国临床保健杂志,2022,25(2):213-217.
[13] KOBUNE M.Diagnosis and treatment of anemia by malnutrition in the elderly[J].Rinsho Ketsueki,2023,64(9):900-907.
[14] BURGOS R,GARCÍA-ALMEIDA J M,MATÍA-MARTÍN P,et al.Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection[J].Rev Endocr Metab Disord,2022,23(2):205-213.
[15] 牟莉莎,龚涛,徐惠旎,等.中式改良DASH饮食对高血压合并2型糖尿病患者营养健康状况的影响研究[J].中国全科医学,2022,25(34):4304-4311.
[16] 杨君茹,何玲玲,高美欣,等.糖基化修饰在代谢相关脂肪性肝病中作用研究进展[J].中国肝脏病杂志(电子版),2022,14(4):20-27.
[17] 程洁,金琳琳,李勇华,等.NRS 2002与PG-SGA营养测评联合用于淋巴瘤患者营养风险评估的价值[J].中华保健医学杂志,2022,24(6):486-488.
[18] 韩辰宇,叶晓梅,张敏.重组人胰高血糖素样肽-1对2型糖尿病合并肥胖患者脂肪组织功能障碍的影响[J].临床内科杂志,2023,40(7):489-490.
[19] GARCÍA-CASARES N,GONZÁLEZ-GONZÁLEZ G,DE LA CRUZ-COSME C,et al.Effects of GLP-1 receptor agonists on neurological complications of diabetes[J].Rev Endocr Metab Disord,2023,24(4):655-672.
[20] SCHEEN A J.Dual GIP/GLP-1 receptor agonists:new advances for treating type-2 diabetes[J].Ann Endocrinol (Paris),2023,84(2):316-321.
[21] YABUT J M,DRUCKER D J.Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease[J].Endocr Rev,2023,44(1):14-32.
[22] 周华.血清胰高血糖素样肽-1水平可预测新诊断2型糖尿病患者的颈动脉粥样硬化[J].内科急危重症杂志,2022,28(3):200-203.
[23] 蒋和平,王劢,吴国荣,等.血清缺氧诱导因子-1α、肾上腺髓质素前体、甘胆酸水平与老年慢性阻塞性肺疾病急性加重期患者肺功能损伤进展的相关性[J].实用临床医药杂志,2022,26(5):122-126.
[24] 汪学耀,张涛,荆成宝.血清总胆汁酸与甘胆酸水平诊断妊娠期肝内胆汁淤积症能力的Meta分析[J].现代检验医学杂志,2020,35(5):73-76.
[25] 喻茂文,汤洪波,陈建军,等.血清甘胆酸、总胆汁酸、胰高血糖素样肽-1在脂肪肝向肝癌转化中的意义及与机体糖脂代谢的关系探讨[J].中国医师进修杂志,2022,45(4):314-318. |